Daniel H Schneiderman insider trades

Open-market stock purchases and sales by Daniel H Schneiderman, Chief Financial Officer at Pasithea Therapeutics Corp, from SEC Form 4 filings since Apr 5, 2013.

Recent trades

DateStockTradeValue
May 1, 2026KTTA Pasithea Therapeutics CorpBought (not open market)—
Nov 28, 2025KTTA Pasithea Therapeutics CorpBought (not open market)$20K
Oct 24, 2025KTTA Pasithea Therapeutics CorpBought (not open market)—

Companies traded

  • KTTA Pasithea Therapeutics Corp: other filings, last May 1, 2026
  • FWBI First Wave BioPharma, Inc: other filings, last Jan 3, 2022
  • AZRX AzurRx BioPharma, Inc: other filings, last Jun 30, 2021
  • MTST MetaStat, Inc: other filings, last Jan 12, 2018
  • MTST.OB MetaStat, Inc: other filings, last Apr 4, 2017

Get free alerts when Daniel H Schneiderman files a new trade →